64Cu-DOTA-NT-Cy5.5

N/A

Report date: 2025/11/20 16:03:49

NME

Base Information

Drug Name64Cu-DOTA-NT-Cy5.5

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Copper > 64CuRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionNeurotensin receptor 1 binders

TargetsNeurotensin receptor 1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of North Carolina At Chapel Hill

China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of North Carolina At Chapel Hill

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A